Advice
following an abbreviated submission
magnesium aspartate dihydrate (Magnaspartate®) is accepted for use within NHS Scotland.
Indication under review: for the treatment and prevention of magnesium deficiency, as diagnosed by a doctor.
This is the first licensed oral magnesium product to be available in the UK for the treatment and prevention of magnesium deficiency. Magnesium supplementation has previously been available as a food supplement.
Download detailed advice50KB (PDF)
Medicine details
- Medicine name:
- magnesium aspartate dehydrate (Magnaspartate)
- SMC ID:
- 1042/15
- Indication:
- for the treatment and prevention of magnesium deficiency, as diagnosed by a doctor.
- Pharmaceutical company
- Kora Healthcare
- BNF chapter
- Nutrition and blood
- Submission type
- Abbreviated
- Status
- Accepted
- Date advice published
- 08 June 2015